Project

I6T-MC-AMAM

Ongoing - recruitment active · 2019 until 2022

Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Ongoing - recruitment active
Start Date
2019
End Date
2022
Financing
Industry
Brief description/objective

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active-
Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Crohn's Disease